Product Programs
Overview
Pronota is developing diagnostic blood tests with relevant clinical proof of concept.
Our four programs are selected with great care, taking into account significant unmet diagnostic needs, commercial opportunities, and access to unique sample cohorts, married with the unique benefits of our protein biomarker discovery engines.
Pronota has four programs in its pipeline in the areas of cardio-renal disease, pre-eclampsia, sepsis and ovarian cancer. In all cases projects are being driven forward aggressively in multi-center validation studies together with the support of key clinical opinion leaders.